Q5100 Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg

Short descriptor: Inj ustekinumab-kfce, 1 mg

✓ Active HCPCS Level II 2026
Open Q5100 in the app →

Look up Q5100 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q5100 is the HCPCS Level II code for Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2025-07-01
2026 Maintenance
No change this year

References

Cite This Page

Reference Q5100 with the canonical source and edition:

Q5100 — Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q5100

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q5100

Related Codes in Section Q

← Q5099 Inj ustekinumab-stba, 1 mg Q5101 → Injection, zarxio
Q5009 Hospice/home hlth, place nos Q5010 Hospice home care in hospice Q5098 Inj ustekinumab-srlf, 1 mg Q5099 Inj ustekinumab-stba, 1 mg Q5101 Injection, zarxio Q5102 Inj., infliximab biosimilar Q5103 Injection, inflectra Q5104 Injection, renflexis Q5105 Inj retacrit esrd on dialysi Q5106 Inj retacrit non-esrd use
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial